Emma Droste

Graduate School

Works (1)

Updated: April 5th, 2024 17:13

2023 article

Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption

Thomas, R., Wiley, C. A., Droste, E. L., Robertson, J., Inman, B. A., & Breen, M. (2023, April 20). (T. Leeb, Ed.). PLoS Genetics, Vol. 19.

By: R. Thomas n, C. Wiley n, E. Droste n, J. Robertson n, B. Inman* & M. Breen n

Ed(s): T. Leeb

MeSH headings : Dogs; Animals; Humans; Urinary Bladder Neoplasms / genetics; Urinary Bladder Neoplasms / veterinary; Carcinoma, Transitional Cell / genetics; Carcinoma, Transitional Cell / veterinary; Proto-Oncogene Proteins B-raf / genetics; Exome Sequencing; Mutation; MAP Kinase Kinase 1 / genetics
topics (OpenAlex): Veterinary Oncology Research; Infectious Diseases and Mycology; Bladder and Urothelial Cancer Treatments
TL;DR: It is suggested that short in-frame deletions within BRAF exon 12 and MAP2K1 exons 2 and 3 in UDV595E cases are alternative MAPK-pathway activating events that may have significant therapeutic implications for selecting first-line treatment for canine UC. (via Semantic Scholar)
Sources: Web Of Science, NC State University Libraries, ORCID
Added: May 15, 2023

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.